Across the Nutra-verse: New York’s hemp regulations, Poland’s new vitamin level limits, and more
USA
New York hemp regulations sets up strictly regulated cannabinoid market
Recent regulations in New York to govern hemp cultivation within State also create a regulatory framework specific to the trade in cannabinoid extracts and finished goods.
Gov. Andrew Cuomo signed the measure into law last week. It requires hemp processors to obtain licenses and stipulates that they must grow hemp varieties with no more that 0.3% THC levels by dry weight, which conforms to the federal definition of industrial hemp as opposed to marijuana.
In addition, the law seeks to specifically regulate the trade in cannabinoid extracts and finished goods, requiring additional licenses, third party lab testing and other requirements that seem to go beyond what federal law mandates for the manufacture and sale of garden-variety dietary supplements.
Commenting to NutraIngredients-USA, Marc Ullman, of counsel with the firm Rivkin Radler, said: “It clearly contemplates a market in cannabinoids. The potential for a well-ordered marketplace appears to exist. We essentially have licensing provisions from farm to shelf, and there is a framework for the state to establish an intrastate market.”
For more on this, please click HERE.
Europe
Poland adopts further vitamin and nutrient supplement limits
Poland’s Diet Supplement Council have added permitted levels for vitamins, minerals, caffeine and white mulberry preparations to their guidelines.
Levels for caffeine have been set at no more than 200 mg per serving.
Council also set maximum levels for pantothenic acid (Vitamin B5) at 10 mg per day, or 200 mg/day for other chemical forms of the vitamin such as calcium D-pantothenate, sodium D-pantothenate and dexapanthenol.
Levels for thiamine (vitamin B1) were set at 100mg/day; for riboflavin (vitamin B2) at 40mg/day; cobalamin (vitamin B12) at 100 micrograms (µg)/day; and iodine at 150µg/day with a level set at 200µg/day for dietary supplements intended for pregnant and lactating women.
Preparations containing the white mulberry plant (Morus alba L.) focus on the enzyme inhibitor 1-deoxynojirymycin (DNJ), which is found in mulberry leaves. Maximum levels of DNJ were set at no more than 10mg daily.
For more on this, please click HERE.
Asia
New Zealand firm invests $20 million in marine extracts center
Seafood company Sanford is building a NZ$20 million (US$13 million) marine extracts center in Blenheim, New Zealand, to produce high quality nutrition products, with the focus on a range of products including Greenshell mussel powder and oil.
Mussel powder is known for assisting with inflammation management in athletes, older people or people suffering from joint aches and pains. The mussel oil is a concentrated form of the powder, and can be used in smaller dosages, with similar benefits.
Sanford’s general manager of innovation, Andrew Stanley told NutraIngredients-Asia: “The demand for marine extracts in APAC is strong and growing. New Zealand has a unique advantage in that we are the home of the New Zealand Greenshell mussel which grows only here and is known for assisting with inflammation management.”
The firm is already producing the powder from a small facility in Blenheim, but aims to increase production with the new center.
For more on this, please click HERE.
